PROCEPT BioRobotics announces preliminary Q4 revenue of $9.8-10.1M, FY 2021 revenue $34.1-34.4M

PROCEPT BioRobotics Corp

2021-FY EPS reported -$3.63 revenue$34,473,000

Q4 2021 revenue expected $9.8M-$10.1M, up from $3.2M in Q4 2020.
FY 2021 revenue expected $34.1M-$34.4M, up from $7.7M in FY 2020.
U.S. Q4 revenue $8.4M-$8.7M; systems $5.0M, consumables $3.4M; international $1.4M.
CEO states results exceeded expectations due to system sales, procedure adoption, and commercial team expansion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.